Anti-sonic hedgehog immunohistochemistry accurately diagnosis ballooning degeneration in both metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease

Read full text Summarise with VIRAT
Authors: Guillaume Hénin, Salomé Declerck, Alexis Goffaux, Pamela Baldin, Paulina Henry, Caroline Bouzin, Isabelle Anne Leclercq, Peter Starkel, Annette Gouw, Christine Sempoux, Nicolas Lanthier, International liver congress - EASL
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and aims Ballooning degeneration is a key histological marker of steatotic liver disease (SLD) severity, but it remains difficult to identify reliably and shows poor inter-observer agreement. Sonic hedgehog pathway is involved in ballooning pathogenesis. Our objective was to assess the diagnostic accuracy of anti-SHH immunohistochemistry (IHC) for the diagnosis of ballooning degeneration in SLD. Method Recruited participants with a diagnosis of SLD (MASLD or ALD) on imaging and increased liver stiffness (≥ 9kPa, M probe, Fibroscan®) underwent liver biopsy. Four blinded pathologists scored hematoxylin-eosin stained slides for steatosis and activity including ballooning. Anti-SHH IHC was performed on the same liver samples and quantified manually (positive cells per field at 40-fold magnification) by two untrained observers blinded to the pathology score. Results Eighty-eight participants with SLD (52 with MASLD, 36 with ALD) were prospectively recruited and underwent liver biopsy. Median self-reported alcohol consumption was 80 units per week in the ALD group. Mean BMI was significantly higher in the MASLD group (34.7 kg/m²) compared to the ALD group (27.3 kg/m²; p < 0.0001). 38% of cases were classified by pathologists as fibrosis grade 0-1 (F0-1), 30% as F2, 26% as F3 and 6% as F4 in the pooled SLD group. 46% of MASLD cases were classified as ballooning grade 0 (B0), 27% as B1 and 27% as B2 while 61% of ALD were classified as B0, 14% as B1 and 25% as B2. The count of SHH positive cells strongly correlated between untrained observers (r = 0.89, p < 0.0001) across the whole SLD cohort. SHH positive density positively correlated with ballooning grades in MASLD (r = 0.71, p < 0.0001), ALD (r = 0.75, p < 0.0001) and pooled SLD (r = 0.69, p < 0.0001). In particular, the median SHH density was 0.03 for B0, 0.16 for B1 and 0.96 for B2 in the pooled SLD group (p < 0.0001). SHH density showed a very high diagnostic accuracy for the diagnosis of ballooning in MASLD (AUC = 0.83, p < 0.0001), ALD (AUC = 0.94, p < 0.0001) and pooled SLD (AUC = 0.86, p < 0.0001). Conclusion Anti-SHH IHC is a highly accurate tool for the diagnosis of ballooning by untrained observers in MASLD and ALD highlighting its potential utility in clinical practice and research in the topic of SLD.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Alcohol Consumption and Health Effects Liver physiology and pathology

Publication details

Journal / source
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))
Publication date
1 January 2026
Language
EN